Learning Objectives:
1. Identify the evidence supporting the role of LDL cholesterol in atherosclerotic cardiovascular disease risk, including medicines to lower LDL cholesterol.
2. Identify prior and ongoing investigations of HDL cholesterol and triglycerides in atherosclerotic cardiovascular disease risk.
3. Understand the roles of emerging biomarkers, such as lipoprotein(a) and apolipoprotein B, in current management of atherosclerotic cardiovascular disease.
Негізгі бет Hyperlipidemia: Latest Concepts
Пікірлер: 4